European manufacturer with an existing India subsidiary

Management decision

India revenue was growing but below plan; management could not tell whether the constraint was coverage, price, product, channel or execution.

What made the decision difficult

• Legacy channel relationships
• Regional performance differences
• Pricing leakage
• Incomplete CRM/account data
• Existing organization made change politically harder

10–13 weeks

Staged so management can stop, modify or increase commitment as evidence improves.

Evidence → decision → execution

Diagnose uncertainty, validate it in India, make an explicit investment gate, then execute the approved next stage.

Solution design

• Revenue decomposition
• Territory/account whitespace
• Win/loss and price leakage analysis
• Channel productivity
• Product/localization gaps
• Operating cadence and accountability redesign
• Focused growth experiments

KPIs

End execution plan

• Weeks 1–3: diagnostic baseline
• Weeks 4–6: account/channel evidence
• Weeks 7–9: constraint tests
• Weeks 10–13: prioritized interventions
• Next 90 days: weekly growth cockpit, named owners and stop/scale rules

Government / regulatory / legal

• Existing entity compliance health check
• GST/tax and intercompany/transfer-pricing implications of changes
• Employment/contract changes legally reviewed
• Product/regulatory changes checked before localization or new offers
• Competition/channel contract implications reviewed

Control: applicability must be confirmed for the actual product, activity, entity, state and transaction by the appropriate qualified specialist/authority.

Decision state

A constraint-led growth plan that reallocates effort toward measurable India whitespace

Why it matters

Treats India expansion as an operating-system problem, not another market-entry study.